Detalhe da pesquisa
1.
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Antimicrob Agents Chemother
; 67(4): e0005323, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995219
2.
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.
Clin Infect Dis
; 73(3): e643-e651, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382405
3.
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
J Infect Dis
; 222(Suppl 1): S52-S62, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645163
4.
HIV Care Initiation: A Teachable Moment for Smoking Cessation?
Nicotine Tob Res
; 20(9): 1109-1116, 2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29059424
5.
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
J Neurovirol
; 23(5): 704-712, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28791662
6.
The role of pain in quitting among human immunodeficiency virus (HIV)-positive smokers enrolled in a smoking cessation trial.
Subst Abus
; 38(3): 249-252, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328303
7.
The role of BMI change on smoking abstinence in a sample of HIV-infected smokers.
AIDS Care
; 28(5): 603-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26666313
8.
Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic.
AIDS Behav
; 18(3): 544-54, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23605155
9.
Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.
AIDS Care
; 26(10): 1229-35, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24635664
10.
The influence of HIV disease events/stages on smoking attitudes and behaviors: project STATE (Study of Tobacco Attitudes and Teachable Events).
BMC Public Health
; 14: 149, 2014 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517853
11.
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques.
J Control Release
; 366: 18-27, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142963
12.
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
AIDS
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489580
13.
Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS.
Clin Infect Dis
; 57(4): 608-15, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704120
14.
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primates.
J Control Release
; 358: 116-127, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120032
15.
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
AIDS
; 37(3): 423-434, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525544
16.
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates.
Sci Transl Med
; 15(702): eadg2887, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379369
17.
Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes.
Nicotine Tob Res
; 14(1): 106-10, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21669958
18.
Longitudinal Effects of Combination Antiretroviral Therapy on Cognition and Neuroimaging Biomarkers in Treatment-Naive People With HIV.
Neurology
; 99(10): e1045-e1055, 2022 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219802
19.
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates.
Adv Ther (Weinh)
; 4(3)2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997267
20.
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Nat Med
; 27(10): 1718-1724, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621054